Global Precision Medicine Software Market

Global Precision Medicine Software Market was valued USD 1.78  Bn in 2023 and is expected to reach USD 3.89 Bn by 2030, at CAGR of 11.77% during forecast period.

The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology:-Request Free Sample Report

Global Precision Medicine Software Market Dynamics:

Latest advancements in applications of big data technologies for exact detection of diseases will positively impact the precision medicine market share during the forecast period. Big data analytics are beneficial in chronic disease management. Moreover, software also provides improved clinical workflow. Introduction of such software that usually has improved capacity to store huge amount of genetic data ensuring faster patient recovery will be helpful for the precision medicine industry growth. Also, key industry players focus their efforts on improvement of software that supports drug discovery processes. Software specifically designed to develop precision medicines applied in treatment of chronic diseases as well as genetic diseases ensuring quick patient recovery will expand the precision medicine market size in upcoming years.

According to Application, Oncology segment was holding the largest share of Precision Medicine Software Market in 2023. Large share of this segment can be recognized to the growing occurrence of cancer, rising funding in cancer research, capable applications of precision medicine in oncology research, and better investments by government organizations in precision medicine software.

North American market was holding the largest share of precision medicine software in 2023. North America in the precision medicine software market can be attributed to factors like growing HCIT investments in the region, presence of regulatory mandates supporting market growth in US, and growing digitalization and favorable funding initiatives by the Canadian government.

Industry players implement tactical decisions that supports them with competitive advantage. As, in January 2018, Roche entered into collaboration with Syapse. Sypase is a leading precision medicine company with wide-ranging product portfolio. This collaboration will extend Roche’s precession medicine portfolio which will increase company’s revenue share in the market.

Large academic medical centers and professional societies are already promoting from partnerships with IT start-up companies dedicated on precision medicine. Not only does the implementation of these specific platforms help further the advances in precision medicine, but these relationships substitute the competitive environments which will help driving innovation to new heights.

Future of the precision medicine marketplace is a bright one. Because of relatively limited adoption rate the opportunities for precision medicine growth and integration in a different array of technologies makes this an area worth watching and one we look forward to exploring further.

This report aims at answering several characteristics of global precision medicine market with the help of key factors driving the market, restraints and challenges which can possibly prevent the overall market growth, and the current growth opportunities that are going to figure out the future insight of the market expansion. The report includes an in-depth analysis of the key ecosystem players and key policies & developments taking place in this market. The research study reflects the market share analysis for a complete understanding of global precision medicine market and measures the factors governing the same.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding precision medicine software market dynamics, structure by identifying and analyzing the market segments and project the global market size.

Further, report also focuses on competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in near future to emerging segment in precision medicine software market.

Global Precision Medicine Software Market, Key Highlights:

Global Precision Medicine Software Market analysis and forecast, in terms of value.

Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Precision Medicine Software Market

Global Precision Medicine Software Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

Global market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

Global Precision Medicine Software Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Precision Medicine Software Market are also profiled.

The report has considered the base year of 2023 and past four years trend. 2023 figures are at actuals, however due to different dynamics of year 2023, market forecast is not only dependent upon 2023, but on the basis of 2018-2023.

Scope of Global Precision Medicine Software Market: Inquire before buying

Global Precision Medicine Software Market by Region:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Precision Medicine Software Key Player

1. Syapse, Inc.
2. 2bPrecise LLC
3. Foundation Medicine, Inc.
4. Fabric Genomics
5. SOPHiA GENETICS SA
6. PierianDx, Inc
7. N-of-One, Inc.
8. Human Longevity, Inc.
9. Translational Software, Inc
10.Sunquest Information Systems Inc
11.Gene42, Inc.
12.LifeOmic Health, LLC
13.NantHealth, Inc
14.Tempus Labs, Inc.
15.Flatiron Health, Inc.
16.IBM Watson Group
17.Koninklijke Philips N.V.

FAQ
1] What segments are covered in the Global Precision Medicine Software Market report?
Ans. The segments covered in the Global Market report are based on Delivery Mode,  Application and End-User.

2] Which region is expected to hold the highest share in the Global Precision Medicine Software Market?
Ans. North America region is expected to hold the highest share in the Global  Market.

3] What is the market size of the Global Precision Medicine Software Market by 2030?
Ans. The market size of the Global Market by 2030 is expected to reach USD 3.89 Bn.

4] What is the forecast period for the Global Precision Medicine Software Market?
Ans. The forecast period for the Global Market is 2024-2030.

5] What was the market size of the Global Precision Medicine Software Market in 2023?
Ans. The market size of the Global Market in 2023 was valued at USD 1.78 Bn.